(Q46416613)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18720192%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

title

Inhibition of glycogen synthase kinase by curcumin: Investigation by simulated molecular docking and subsequent in vitro/in vivo evaluation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18720192%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18720192%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Yasser Bustanji

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18720192%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Hatim Samir AlKhatib

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18720192%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

author name string

Ihab M Almasri

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18720192%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Mohamed A S Al-Ghussein

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18720192%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Mohammad K Mohammad

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18720192%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

publication date

1 June 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18720192%20AND%20SRC:MED&resulttype=core&format=json

Journal of Enzyme Inhibition and Medicinal Chemistry

12 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18720192%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18720192%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

page(s)

771-778

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18720192%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18720192%20AND%20SRC:MED&resulttype=core&format=json

Multiple biological activities of curcumin: a short review

12 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F14756360802364377

Molecular orbital basis for yellow curry spice curcumin's prevention of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802364377

NMR study of the solution structure of curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802364377

Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802364377

Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L.) suppress an increase in blood glucose level in type 2 diabetic KK-Ay mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802364377

Antioxidant activity of curcumin and related compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802364377

Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802364377

Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802364377

Synthesis and exploration of novel curcumin analogues as anti-malarial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802364377

Curcumin: the story so far.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802364377

Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802364377

Clinical studies with curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802364377

Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802364377

Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802364377

Glycogen synthase kinase-3 beta regulates NF-kappa B1/p105 stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802364377

Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802364377

Glycogen synthase kinase 3 (GSK-3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802364377

GSK-3 inhibitors: discoveries and developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802364377

Olanzapine inhibits glycogen synthase kinase-3beta: an investigation by docking simulation and experimental validation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802364377

Pharmacophore modeling, quantitative structure-activity relationship analysis, and in silico screening reveal potent glycogen synthase kinase-3beta inhibitory activities for cimetidine, hydroxychloroquine, and gemifloxacin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802364377

Plasmodium falciparum glycogen synthase kinase-3: molecular model, expression, intracellular localisation and selective inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802364377

Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802364377

Prospects for kinase activity modulators in the treatment of diabetes and diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802364377

Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802364377

Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802364377

Glycogen synthase kinase 3beta phosphorylates tau at both primed and unprimed sites. Differential impact on microtubule binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802364377

First non-ATP competitive glycogen synthase kinase 3 beta (GSK-3beta) inhibitors: thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802364377

The statistical-thermodynamic basis for computation of binding affinities: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802364377

Evaluation of docking performance: comparative data on docking algorithms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802364377

Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802364377

Multiple active site corrections for docking and virtual screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802364377

Glycogen Synthase Kinase-3 from Rabbit Skeletal Muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802364377